Literature DB >> 22476416

[The oncofetal gene survivin - a possible target gene for regenerative therapy concepts in cartilaginous tissue].

P Lechler1, M Handel, S Anders, S Balakrishnan, J Grifka.   

Abstract

Survivin, the smallest member of the inhibitor of the apoptosis protein gene family (IAP) is a key molecule for mammalian cell cycle regulation and cellular survival. Of note these functions have been thought to be limited to embryonic and malignant tissues. However, a growing body of evidence indicates a limited expression of survivin in some highly specific adult tissues and cells. In the present study it has been demonstrated that the antiapoptotic protein survivin is re-expressed in osteoarthritic human cartilage and primary human chondrocytes. Furthermore, the data indicated that survivin significantly affects cell cycle regulation and cellular survival. The modulation of survivin expression and function in cartilaginous tissues might be important for understanding osteoarthritis and the development of regenerative strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476416     DOI: 10.1007/s00132-011-1852-0

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  19 in total

1.  The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells.

Authors:  Philipp Lechler; Jens Schaumburger; Franz X Köck; Sanjeevi Balakrishnan; Stavros Doukas; Lukas Prantl; Joachim Grifka
Journal:  Calcif Tissue Int       Date:  2011-06-15       Impact factor: 4.333

Review 2.  Survivin, a cancer target with an emerging role in normal adult tissues.

Authors:  Seiji Fukuda; Louis M Pelus
Journal:  Mol Cancer Ther       Date:  2006-05       Impact factor: 6.261

Review 3.  Interaction of chondrocytes, extracellular matrix and growth factors: relevance for articular cartilage tissue engineering.

Authors:  P M van der Kraan; P Buma; T van Kuppevelt; W B van den Berg
Journal:  Osteoarthritis Cartilage       Date:  2002-08       Impact factor: 6.576

4.  Survivin-induced Aurora-B kinase activation: A mechanism by which APC mutations contribute to increased mitoses during colon cancer development.

Authors:  Tao Zhang; Jeremy Z Fields; Lynn Opdenaker; Tomas Otevrel; Emi Masuda; Juan P Palazzo; Gerald A Isenberg; Scott D Goldstein; Marc Brand; Bruce M Boman
Journal:  Am J Pathol       Date:  2010-11-05       Impact factor: 4.307

Review 5.  Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice.

Authors:  Aaron D Schimmer
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

6.  Chondrocyte death and cartilage degradation after autologous osteochondral transplantation surgery in a rabbit model.

Authors:  Lawrence V Gulotta; Jonas R Rudzki; David Kovacevic; Christopher C T Chen; Dejan Milentijevic; Riley J Williams
Journal:  Am J Sports Med       Date:  2009-05-15       Impact factor: 6.202

Review 7.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

8.  Control of apoptosis and mitotic spindle checkpoint by survivin.

Authors:  F Li; G Ambrosini; E Y Chu; J Plescia; S Tognin; P C Marchisio; D C Altieri
Journal:  Nature       Date:  1998-12-10       Impact factor: 49.962

9.  The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro.

Authors:  Philipp Lechler; Tobias Renkawitz; Valentina Campean; Sanjeevi Balakrishnan; Markus Tingart; Joachim Grifka; Jens Schaumburger
Journal:  BMC Cancer       Date:  2011-04-02       Impact factor: 4.430

10.  The oncofetal gene survivin is re-expressed in osteoarthritis and is required for chondrocyte proliferation in vitro.

Authors:  Philipp Lechler; Sanjeevi Balakrishnan; Jens Schaumburger; Susanne Grässel; Clemens Baier; Joachim Grifka; Rainer H Straub; Tobias Renkawitz
Journal:  BMC Musculoskelet Disord       Date:  2011-07-05       Impact factor: 2.362

View more
  1 in total

1.  Shikonin Derivatives Inhibit Inflammation Processes and Modulate MAPK Signaling in Human Healthy and Osteoarthritis Chondrocytes.

Authors:  Birgit Lohberger; Heike Kaltenegger; Nicole Eck; Dietmar Glänzer; Patrick Sadoghi; Andreas Leithner; Rudolf Bauer; Nadine Kretschmer; Bibiane Steinecker-Frohnwieser
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.